ADIPOQ and metabolic syndrome: In a pooled analysis, increased levels of the anti-inflammatory adipose tissue hormone adiponectin were associated with metabolic syndrome and obesity; however, psoriasis severity and anti-psoriatic treatment with secukinumab or etanercept had no relevant impact on adiponectin levels [34].